LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Dexamethasone in severe COVID-19 infection: A case series.

    Hassan, Mohamed Eliwa / Hasan, Hasan Msn / Sridharan, Kannan / Elkady, Adel / ElSeirafi, Mohamed Ma

    Respiratory medicine case reports

    2020  Volume 31, Page(s) 101205

    Abstract: Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome. ...

    Abstract Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.
    Keywords covid19
    Language English
    Publishing date 2020-08-28
    Publishing country England
    Document type Case Reports
    ZDB-ID 2666110-X
    ISSN 2213-0071
    ISSN 2213-0071
    DOI 10.1016/j.rmcr.2020.101205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Causative bacteria of ventilator-associated pneumonia in intensive care unit in Bahrain: Prevalence and antibiotics susceptibility pattern.

    Hassan, Mohamed Eliwa / Al-Khawaja, Safaa Abdulaziz / Saeed, Nermin Kamal / Al-Khawaja, Sana Abdulaziz / Al-Awainati, Mahmood / Radhi, Sara Salah Yusuf / Alsaffar, Mohamed Hameed / Al-Beltagi, Mohammed

    World journal of critical care medicine

    2023  Volume 12, Issue 3, Page(s) 165–175

    Abstract: Background: Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs two calendar days following endotracheal intubation or after that. It is the most common infection encountered among intubated patients. VAP incidence showed wide ... ...

    Abstract Background: Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs two calendar days following endotracheal intubation or after that. It is the most common infection encountered among intubated patients. VAP incidence showed wide variability between countries.
    Aim: To define the VAP incidence in the intensive care unit (ICU) in the central government hospital in Bahrain and review the risk factors and the predominant bacterial pathogens with their antimicrobial susceptibility pattern.
    Methods: The research was a prospective cross-sectional observational study over six months from November 2019 to June 2020. It included adult and adolescent patients (> 14 years old) admitted to the ICU and required intubation and mechanical ventilation. VAP was diagnosed when it occurred after 48 h after endotracheal intubation using the clinical pulmonary infection score, which considers the clinical, laboratory, microbiological, and radiographic evidence.
    Results: The total number of adult patients admitted to the ICU who required intubation and mechanical ventilation during the study period was 155. Forty-six patients developed VAP during their ICU stay (29.7%). The calculated VAP rate was 22.14 events per 1000 ventilator days during the study period, with a mean age of 52 years ± 20. Most VAP cases had late-onset VAP with a mean number of ICU days before the development of VAP of 9.96 ± 6.55. Gram-negative contributed to most VAP cases in our unit, with multidrug-resistant Acinetobacter being the most identified pathogen.
    Conclusion: The reported VAP rate in our ICU was relatively high compared to the international benchmark, which should trigger a vital action plan for reinforcing the implementation of the VAP prevention bundle.
    Language English
    Publishing date 2023-06-09
    Publishing country United States
    Document type Journal Article
    ISSN 2220-3141
    ISSN 2220-3141
    DOI 10.5492/wjccm.v12.i3.165
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Dexamethasone in severe COVID-19 infection: A case series

    Hassan, Mohamed Eliwa / Hasan, Hasan Msn / Sridharan, Kannan / Elkday, Adel / ElSeirafi, Mohamed Ma

    Respir Med Case Rep

    Abstract: Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome. ...

    Abstract Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #733633
    Database COVID19

    Kategorien

  4. Article ; Online: Dexamethasone in severe COVID-19 infection

    Hassan, Mohamed Eliwa / Hasan, Hasan MSN. / Sridharan, Kannan / Elkady, Adel / ElSeirafi, Mohamed MA.

    Respiratory Medicine Case Reports

    A case series

    2020  Volume 31, Page(s) 101205

    Keywords Pulmonary and Respiratory Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2666110-X
    ISSN 2213-0071
    ISSN 2213-0071
    DOI 10.1016/j.rmcr.2020.101205
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top